Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$0.81 - $1.51 $2,847 - $5,309
-3,516 Reduced 98.51%
53 $0
Q4 2021

Feb 14, 2022

BUY
$1.3 - $2.96 $2,405 - $5,476
1,850 Added 107.62%
3,569 $5,000
Q3 2021

Nov 12, 2021

BUY
$2.35 - $3.93 $124 - $208
53 Added 3.18%
1,719 $5,000
Q2 2021

Aug 13, 2021

BUY
$3.49 - $11.34 $5,814 - $18,892
1,666 New
1,666 $7,000

About PALISADE BIO, INC.


  • Ticker PALI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,240,200
  • Market Cap $122M
  • Description
  • Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. Its lead therapeutic candidate is LB1148, an oral liquid formulation of the digestive enzym...
More about PALI
Track This Portfolio

Track Evermay Wealth Management LLC Portfolio

Follow Evermay Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.